Browse > Article

Assessment of Lipopolysaccharide-binding Activity of Bifidobacterium and Its Relationship with Cell Surface Hydrophobicity, Autoaggregation, and Inhibition of Interleukin-8 Production  

Park, Myeong-Soo (Research Institute, BIFIDO Co., Ltd.)
Kim, Min-Jeong (Department of Food and Nutrition, Research Institute of Human Ecology, Seoul National University)
Ji, Geun-Eog (Research Institute, BIFIDO Co., Ltd.)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.7, 2007 , pp. 1120-1126 More about this Journal
Abstract
This study was performed to screen probiotic bifidobacteria for their ability to bind and neutralize lipopolysaccharides (LPS) from Escherichia coli and to verify the relationship between LPS-binding ability, cell surface hydrophobicity (CSH), and inhibition of LPS-induced interleukin-8 (IL-8) secretion by HT-29 cells of the various bifidobacterial strains. Ninety bifidobacteria isolates from human feces were assessed for their ability to bind fluorescein isothiocyanate (FITC)-labeled LPS from E. coli. Isolates showing 30-60% binding were designated LPS-high binding (LPS-H) and those with less than 15% binding were designated LPS-low binding (LPS-L). The CSH, autoaggregation (AA), and inhibition of LPS-induced IL-8 release from HT-29 cells of the LPS-H and LPS-L groups were evaluated. Five bifidobacteria strains showed high levels of LPS binding, CSH, AA, and inhibition of IL-8 release. However, statistically significant correlations between LPS binding, CSH, AA, and reduction of IL-8 release were not found. Although we could isolate bifidobacteria with high LPS-binding ability, CSH, AA, and inhibition of IL-8 release, each characteristic should be considered as strain dependent. Bifidobacteria with high LPS binding and inhibition of IL-8 release may be good agents for preventing inflammation by neutralizing Gram-negative endotoxins and improving intestinal health.
Keywords
Aggregation; bifidobacteria; cell surface hydrophobicity; interleukin-8; lipopolysaccharides;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 5  (Related Records In Web of Science)
연도 인용수 순위
1 Bibiloni, R., R. N. Fedorak, G W. Tannock, K. L. Madsen, P. Gionchetti, M. Campieri, C. De Simone, and R. B. Sartor. 2005. VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100: 1539-1546   DOI   ScienceOn
2 Boris, S., J. E. Suarez, and C. Barbes. 1997. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J. Appl. Microbiol. 83: 413-420   DOI   ScienceOn
3 Cario, E. and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68: 7010-7017   DOI   ScienceOn
4 Enrica, C., G. Simone, M. Diego, T. Isabella, and P. Carlo. 2005. Condition affecting cell surface properties of human intestinal bifidobacteria. Antonie Van Leeuwenhoek 88: 207-219   DOI   ScienceOn
5 Furrie, E., S. Macfarlane, A. Kennedy, J. H. Cummings, S. V. Walsh, D. A. O'Neil, and G. T. Macfarlane. 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: A randomised controlled pilot trial. Gut 54: 242-249   DOI   ScienceOn
6 Guarner, F. and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet 361: 512-519   DOI   ScienceOn
7 Kim, H. Y. and G. E. Ji. 2006. Effect of viability and integrity of Bifidobacterium on suppression of allergy in mice. J. Microbiol. Biotechnol. 16: 1010-1016   과학기술학회마을
8 McCarthy, J., L. O'Mahony, L. O'Callaghan, B. Sheil, E. E. Vaughan, N. Fitzsimons, J. Fitzgibbon, G. C. O'Sullivan, B. Kiely, J. K. Collins, and F Shanahan. 2003. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52: 975-980   DOI   ScienceOn
9 Schiffrin, E. and G. Kociubinski. 2002. Endotoxin binding lactic acid bacteria and bifidobacteria. In Patent Publication Number WO 02/062360 AI
10 Alander, M., R. Korpela, M. Saxelin, T. Vilpponen-Salmela, T. Matilla-Sandholm, and A. Wright. 1997. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett. Appl. Microbiol. 24: 361-364   DOI   ScienceOn
11 De Dooy, J. J., L. M. Mahieu, and H. P. Van Bever. 2001. The role of inflammation in the development of chronic lung disease in neonates. Eur. J. Ped. 160: 457-463   DOI   ScienceOn
12 Meijssen, M. A., S. L. Brandwein, H. C. Reinecker, A. K. Bhan, and D. K. Podolsky. 1998. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am. J. Physiol. 274: 472-479   DOI
13 Wadstrom, T. K., M. S. Anderson, L. Axelsson, S. Lindgren, and B. Gullman. 1987. Surface properties of lactobacilli isolate from the small intestine of pigs. J. Appl. Bacteriol. 62: 513-520   DOI
14 Madsen, K., A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachimec, J. Doyle, L. Jewell, and C. De Simone. 2001. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-59l   DOI   ScienceOn
15 Ortega-Cava, C. F, S. Ishihara, M. A. Rumi, K. Kawashima, N. Ishimura, H. Kazumori, J. Udagawa, Y. Kadowaki, and Y. Kinoshita. 2003. Strategic compartmentalization of toll-like receptor 4 in the mouse gut. J. Immunol. 170: 3977-3985   DOI
16 Pedersen, K. and G. W. Tannock. 1989. Colonization of the porcine gastrointestinal tract by lactobacilli. Appl. Environ. Microbiol. 55: 279-283
17 Riedel, C. U., F. Foata, D. Philippe, O. Adolfsson, B. J. Eikmanns, and S. Blum. 2006. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-$\kappa$B activation. World J. Gastroenterol. 12: 3728-3735
18 Freter, M. 1992. Factors affecting the microecology of the gut, pp. 111-145. In R. Fuller (ed.), Probiotics. The Scientific Basis. Chapman and Hall, Glasgow
19 Perez, P. E, Y. Minnaard, E. A. Disalvo, and G. L. De Antoni. 1998. Surface properties of bifidobacterial strains of human origin. Appl. Environ. Microbiol. 64: 21-26
20 Vinderola, C. G, M. Medici, and G Pedigon. 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 96: 230-243   DOI   ScienceOn
21 Scardovi, V. 1986. Genus Bifidobacteria, pp. 1418-1434. In P. H. A. Sneah, N. S. Mair, M. E. Sharpe, and J. G. Holt (eds.), Bergey's Manual of Systematic Bacteriology, vol. 2, Williams and Wilkins, Baltimore
22 Kim, N. J. and G. E. Ji. 2006. Modulatory activity of Bifidobacterium sp. BGN4 cell fractions on immune cells. J. Microbiol. Biotechnol. 16: 584-589   과학기술학회마을
23 Del Re, B., B. Sgorbati, M. Miglioli, and D. Palenzona. 2000. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 32: 438-442
24 De Man, J. C., M. Rogasa, and M. E. Sharpe. 1960. A medium for the cultivation of lactobacilli. J. Appl. Bacteriol. 23: 130-135   DOI
25 Gionchetti, P., F. Rizzello, A. Venturi, P. Brigidi, D. Matteuzzi, G. Bazzocchi, G. Poggioli, M. Miglioli, and M. Campieri. 2000. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebocontrolled trial. Gastroenterology 119: 305-309   DOI   ScienceOn
26 Lim, N. K., J. C. Yoo, T. R. Park, and J. S. So. 1998. The relationship between cell surface hydrophobicity (CSH) and stress tolerance in Bifidobacterium spp. Food Sci. Biotechnol. 7: 66-70
27 Del Re, B., A. Busetto, G. Vignola, B. Sgorbati, and D. Palenzona. 1998. Autoaggregation and adhesion ability in a Bifidobacterium suis strain. Lett. Appl. Microbiol. 27: 307-310   DOI   ScienceOn
28 Kim, I. H., M. S. Park, and G. E. Ji. 2003. Characterization of adhesion of Bifidobacterium sp. BGN4 to human enterocyte-like Caco-2 cells. J. Microbiol. Biotechnol. 13: 276-281
29 Kok, R. G., A. De Waal, F. Schute, G. W. Welling, G. Weeken, and K. J. Hellingwere. 1996. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces. Appl. Environ. Microbiol. 62: 3668-3672
30 Sellon, R. K., S. Tonkonogy, M. Dieleman, L. A. Schultz, W. Grenther, E. Balish, D. M. Rennick, and R. B. Sartor. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66: 5224-5231